Pharm D Solutions Recalls Lipo MIC-12 Injectable Vials for Sterility Concerns
Pharm D Solutions, LLC is recalling 669 vials of Lipo MIC-12 injectable solution due to a lack of sterility assurance. The product was distributed nationwide.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II and involves a lack of sterility assurance in an injectable product, which poses a significant risk of serious health consequences such as infection.
Plain-English summary
Pharm D Solutions, LLC is recalling 669 vials of Lipo MIC-12 (Methylcobalamin, USP 1mg, Methionine USP 15mg, Inositol, FCC 50mg, Choline Chloride, FCC 100 mg) 10 mL Injectable vials. The recall was initiated because of a lack of sterility assurance in the product.
The affected product was distributed nationwide within the United States. The recall includes specific lots with expiration dates ranging from August 18, 2019, to November 2, 2019. The source text does not specify the number of units distributed to specific regions or the exact date the recall was announced.
Consumers and healthcare providers should stop using the affected vials and contact Pharm D Solutions, LLC at 1-844-263-6846 for further instructions. The company is located at 1304 South Loop West, Houston, TX 77054.
The recalled product
- Product
- Lipo MIC-12 (Methylcobalamin, USP 1mg, Methionine USP 15mg, Inositol, FCC 50mg, Choline Chloride, FCC 100 mg) 10 mL Injectable vials, Pharm D. Solutions 1304 South Loop West, Houston, TX 77054, 1-844-263-6846
- Manufacturer
- Pharm D Solutions, LLC
- Category
- Drug — Injectable
- Hazard
- Affected units
- 669
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (7)
- Lot #: 02202019:53/A Exp. 08/18/2019
- 04012019:67/A
- 04022019:47/A Exp. 09/28/2019
- 04042019:04/A Exp. 09/30/2019
- 04082019:38/A Exp. 10/02/2019
- 04302019:49/A Exp. 10/27/2019
- 05062019:09 Exp. 11/02/2019
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 18 recalled by Pharm D Solutions, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 18 products in this recall →Related recalls
Same manufacturer · Pharm D Solutions, LLC
See all →- SeverePharm D Solutions Recalls Sermorelin/GHRP-2 &6 Vials for Sterility Concerns
FDA (Drugs) · 2019-06-19
- SeverePharm D Solutions Recalls Sermorelin Vials Due to Sterility Concerns
FDA (Drugs) · 2019-06-19
- SeverePharm D Solutions Recalls B-Complex Injectable Vials Due to Sterility Concerns
FDA (Drugs) · 2019-06-19
- SevereFDA Recalls Ipamorelin Acetate Injectable Vials Due to Sterility Concerns
FDA (Drugs) · 2019-06-19
- SeverePharm D Solutions Recalls Testosterone Cypionate Vials for Sterility Concerns
FDA (Drugs) · 2019-06-19
Same hazard · lack of sterility
See all →- SevereK.C. Pharmaceuticals Recalls Dry Eye Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Multiple Brands of Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereClear Eyes Redness Relief Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereClear Eyes Redness Relief Eye Drops Recalled for Sterility Assurance Issues
FDA (Drugs) · 2026-09-30
- SevereGentle Eyes Lubricant Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
Similar recalls
- SeverePharm D Solutions Recalls Lipo MIC-12 Compound Injectable Due to Sterility Concerns
FDA (Drugs) · 2018-11-07
- SeverePharm D Solutions Recalls Methylcobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2018-11-07
- SeverePharm D Solutions Recalls Pyridoxine Injectable Due to Sterility Concerns
FDA (Drugs) · 2018-11-07
- SeverePharm D Solutions Recalls HCG Injectable Due to Sterility Concerns
FDA (Drugs) · 2018-11-07
- SeverePharm D Solutions Recalls Bi-Mix Injectable Due to Sterility Concerns
FDA (Drugs) · 2018-11-07
- HighPharm D Solutions Recalls Tri-Mix XL Injectable Due to Sterility Concerns
FDA (Drugs) · 2018-11-07